← Leaderboards
Robert D Ladner
Univ Of Med/Dent Nj-Sch Osteopathic Med
$1,378,161
Attributed
$1,378,161
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,378,161 · 3
By mechanism
R01$795,990 · 1
R21$582,171 · 2
Top collaborators
No co-investigators on record.
Most similar at Univ Of Med/Dent Nj-Sch Osteopathic Med
Same institution · by research overlap
- Salvatore J Caradonna$1,184,117
Others in their field
Top investigators on “Enzyme Activity”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Randall J Bateman · Washington University$47,808,754
- Susan Abushakra · Alzheon, Inc.$47,265,244
- David Heimbrook · Leidos Biomedical Research, Inc.$45,964,082
- Stuart L Schreiber · Harvard University (Medical School)$40,631,496
- Keith O Hodgson · Stanford University$37,935,767
Research focus
Enzyme ActivityNeoplasm /Cancer ChemotherapyWestern BlottingsEnzyme Induction /RepressionCell LineClinical ResearchColon NeoplasmsHuman SubjectUridine TriphosphateMetastasisThymidylate SynthaseImmunocytochemistryHuman Therapy EvaluationMitochondriaCombination ChemotherapyFluorouracilAcid Anhydride HydrolaseFloxuridineIsozymesLeucovorinThymidylate KinaseTransfectionThymidine MonophosphateBiomarker
Grant awards (8)
dUTPase as a Target for Drug Discovery$143,033
R21 · FY2006 · CA · contact PI
dUTPase as a Target for Drug Discovery$146,250
R21 · FY2004 · CA
dUTPase as a Target for Drug Discovery$950
R21 · FY2004 · CA
ROLE OF DUTPASE EXPRESSION IN CANCER CHEMOTHERAPY$265,330
R01 · FY2003 · CA
dUTPase As A Prognostic Marker in Colon Cancer$138,875
R21 · FY2003 · CA
ROLE OF DUTPASE EXPRESSION IN CANCER CHEMOTHERAPY$265,330
R01 · FY2002 · CA
dUTPase As A Prognostic Marker in Colon Cancer$153,063
R21 · FY2002 · CA
ROLE OF DUTPASE EXPRESSION IN CANCER CHEMOTHERAPY$265,330
R01 · FY2001 · CA